Stealth and cunning: hepatitis B and hepatitis C viruses.
作者信息
Wieland Stefan F, Chisari Francis V
机构信息
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
出版信息
J Virol. 2005 Aug;79(15):9369-80. doi: 10.1128/JVI.79.15.9369-9380.2005.
Abstract
摘要
相似文献
1
Stealth and cunning: hepatitis B and hepatitis C viruses.
J Virol. 2005 Aug;79(15):9369-80. doi: 10.1128/JVI.79.15.9369-9380.2005.
2
[T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma].
Dtsch Med Wochenschr. 2002 Oct 25;127(43):2277-9. doi: 10.1055/s-2002-35016.
3
New insights into hepatitis B and C virus co-infection.
J Hepatol. 2009 Sep;51(3):423-5. doi: 10.1016/j.jhep.2009.06.003. Epub 2009 Jun 23.
4
Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses.
J Med Virol. 1995 Jul;46(3):258-64. doi: 10.1002/jmv.1890460316.
5
Immunology of hepatitis B virus and hepatitis C virus infection.
Nat Rev Immunol. 2005 Mar;5(3):215-29. doi: 10.1038/nri1573.
6
Innate detection of hepatitis B and C virus and viral inhibition of the response.
Cell Microbiol. 2015 Sep;17(9):1295-303. doi: 10.1111/cmi.12489. Epub 2015 Aug 18.
7
Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection.
J Virol. 2023 Oct 31;97(10):e0109023. doi: 10.1128/jvi.01090-23. Epub 2023 Oct 3.
8
[Chronic generalized infection caused by hepatitis viruses (clinical morphological analysis)].
Klin Med (Mosk). 1997;75(12):4-7.
9
Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.
J Virol. 2014 May;88(9):5184-8. doi: 10.1128/JVI.03553-13. Epub 2014 Feb 12.
10
[The role of hepatitis B and C virus-specific CTL in the control of viral replication].
Nihon Rinsho Meneki Gakkai Kaishi. 2002 Feb;25(1):79-88.
引用本文的文献
1
Differentiation-associated ISG expression of NK cells in chronic viral infection.
iScience. 2025 Jul 26;28(9):113216. doi: 10.1016/j.isci.2025.113216. eCollection 2025 Sep 19.
2
Regulation of viral hepatitis by N6-methyladenosine RNA methylation.
Emerg Microbes Infect. 2025 Dec;14(1):2544726. doi: 10.1080/22221751.2025.2544726. Epub 2025 Aug 17.
3
Investigation of a two-patch within-host model of hepatitis B viral infection.
ArXiv. 2025 Jul 30:arXiv:2507.23038v1.
4
Hepatocyte-intrinsic innate immunity in hepatitis B virus infection: A focused review.
World J Hepatol. 2025 Jun 27;17(6):104533. doi: 10.4254/wjh.v17.i6.104533.
5
Bistability between acute and chronic states in a Model of Hepatitis B Virus Dynamics.
Math Biosci. 2025 May 31;387:109467. doi: 10.1016/j.mbs.2025.109467.
6
HBV-driven host chromatin accessibility changes affect liver metabolic pathways, iron homeostasis and promote a preneoplastic phenotype.
J Exp Clin Cancer Res. 2025 May 16;44(1):146. doi: 10.1186/s13046-025-03414-7.
7
PGLYRP2 drives hepatocyte-intrinsic innate immunity by trapping and clearing hepatitis B virus.
J Clin Invest. 2025 Feb 13;135(8). doi: 10.1172/JCI188083. eCollection 2025 Apr 15.
8
From the Cytoplasm into the Nucleus-Hepatitis B Virus Travel and Genome Repair.
Microorganisms. 2025 Jan 14;13(1):157. doi: 10.3390/microorganisms13010157.
9
Tissue Determinants of Antiviral Immunity in the Liver.
Z Gastroenterol. 2025 Jan;63(1):65-72. doi: 10.1055/a-2365-3900. Epub 2025 Jan 10.
10
Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression.
Pharmaceuticals (Basel). 2024 Jul 21;17(7):964. doi: 10.3390/ph17070964.
本文引用的文献
1
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
J Virol. 2005 Jun;79(11):7269-72. doi: 10.1128/JVI.79.11.7269-7272.2005.
2
Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2986-91. doi: 10.1073/pnas.0408707102. Epub 2005 Feb 14.
3
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2992-7. doi: 10.1073/pnas.0408824102. Epub 2005 Feb 14.
4
Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.
J Virol. 2005 Mar;79(5):2689-99. doi: 10.1128/JVI.79.5.2689-2699.2005.
5
CD8 epitope escape and reversion in acute HCV infection.
J Exp Med. 2004 Dec 20;200(12):1593-604. doi: 10.1084/jem.20041006.
6
Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.
J Virol. 2004 Dec;78(24):13779-92. doi: 10.1128/JVI.78.24.13779-13792.2004.
7
Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication.
J Virol. 2004 Dec;78(23):13278-84. doi: 10.1128/JVI.78.23.13278-13284.2004.
8
Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection.
Nat Med. 2004 Dec;10(12):1374-8. doi: 10.1038/nm1133. Epub 2004 Nov 7.
9
Intrinsic immunity: a front-line defense against viral attack.
Nat Immunol. 2004 Nov;5(11):1109-15. doi: 10.1038/ni1125.
10
Cell-mediated immunity and the outcome of hepatitis C virus infection.
Annu Rev Microbiol. 2004;58:391-424. doi: 10.1146/annurev.micro.58.030603.123836.
Zotero 插件